January 11, 2026 (InterContinental San Francisco) — We’re pleased to announce that Guohuang Fan, Ph.D., Founder, Chairman, and CEO at Immunophage Biomedical, will speak at the ACCESS ASIA BD Forum @ JPM 2026.
ACCESS ASIA, hosted by YAFO, builds on the success of ACCESS CHINA, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and strategic partners. Taking place on January 11, 2026, at the InterContinental San Francisco, the forum provides a global stage for Asian biotech companies to showcase their innovation, foster partnerships, and explore new business development opportunities. View more information at: https://biotochina.org/
About Immunophage Biomedical
Nanjing Immunophage Biomedical Co., Ltd. is a clinical-stage biotechnology company founded in 2016, focusing on Innovative drug discovery and development for autoimmune diseases, oncology, metabolic diseases, and neurodegenerative disorders. The company targets the root causes of diseases to develop curative therapies. Immunophage has built a robust pipeline of global innovative assets. The pipeline includes IPG11406 (GPR183 antagonist), IPG1094 (MIF inhibitor), IPG7236 (CCR8 small molecule antagonist), IPG0521 (CCR8 mAb antagonist), IPG0916 (CCR6 mAb antagonist), IPG6620 (LPAR5 antagonist), and the other early discovery assets. For more information, please refer to http://www.immunophage.com.cn/
About the speaker
Dr. Fan, the Founder, Chairman, and CEO of Immunophage, has over 30 years of clinical medicine and biomedical research experience and is a renowned expert in cancer biology, immunological and neurological diseases.
About ACCESS ASIA BD Forum @ JPM 2026
ACCESS ASIA BD Forum @ JPM is scheduled to be held on January 11, 2026, at the InterContinental San Francisco, alongside the J.P. Morgan Healthcare Conference Week.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Conference Name: ACCESS ASIA BD Forum @ JPM 2026
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/
MORE INFORMATION
Contact Us
Register as an attendee for ACCESS ASIA BD Forum @ JPM:
For more information, please contact:
Wendi Xiang | Wxiang@yafocapital.com
BioToChina.org 